9/19/2018
One woman’s account of spinal cord stimulator skips realities of medical device safety in U.S.
6/27/2018
FDA approves new marijuana-derived drug, but was the evidence solid? Washington Post doesn’t say
4/17/2018
Immunotherapy prolongs survival, but at what cost? Washington Post needed more on treatment downsides
1/31/2018
Washington Post story on hyperbaric therapy for head injuries notes uncertain benefit–but not potential harms
12/12/2017
Gene therapy and hemophilia: Washington Post wisely tells readers ‘the study has some limitations’
11/14/2017
‘Regular painkillers work as well as opioids for fractures,’ but is this new information?
10/24/2017
Washington Post wisely quantifies severe side effects and deaths from CAR-T cell therapy
8/31/2017
Washington Post’s otherwise well-reported story on ecstasy for PTSD skirts evidence discussion
7/18/2017
Washington Post wisely notes that CAR T-cell therapy may cost at least $300,000
7/6/2017
Washington Post deftly examines lack of evidence for a fuzzy area of psychiatry: animal therapy
